Aquatic Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-40,824
| Closed | -$900K | – | 1621 |
|
|
2024
Q4 | $900K | Sell |
40,824
-212,176
| -84% | -$4.68M | 0.02% | 581 |
|
|
2024
Q3 | $4.56M | Buy |
253,000
+18,600
| +8% | +$335K | 0.12% | 206 |
|
|
2024
Q2 | $3.81M | Buy |
234,400
+187,400
| +399% | +$3.05M | 0.14% | 147 |
|
|
2024
Q1 | $663K | Buy |
47,000
+33,700
| +253% | +$476K | 0.02% | 483 |
|
|
2023
Q4 | $139K | Buy |
+13,300
| New | +$139K | ﹤0.01% | 935 |
|
|
2023
Q3 | – | Sell |
-87,200
| Closed | -$657K | – | 1645 |
|
|
2023
Q2 | $657K | Sell |
87,200
-43,100
| -33% | -$325K | 0.04% | 395 |
|
|
2023
Q1 | $1.15M | Buy |
+130,300
| New | +$1.15M | 0.07% | 253 |
|
|
2022
Q3 | – | Sell |
-57,500
| Closed | -$432K | – | 1543 |
|
|
2022
Q2 | $432K | Buy |
+57,500
| New | +$432K | 0.14% | 181 |
|
|
2022
Q1 | – | Sell |
-52,400
| Closed | -$420K | – | 1514 |
|
|
2021
Q4 | $420K | Buy |
+52,400
| New | +$420K | 0.81% | 5 |
|